Divergent Genomic and Epigenomic Landscapes of Lung Cancer Subtypes Underscore the Selection of Different Oncogenic Pathways during Tumor Development

• William W. Lockwood ,

  * E-mail: william.lockwood@nih.gov

  Current address: Cancer Biology and Genetics Section, Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  Affiliation Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada

  ⨯
• Ian M. Wilson,

  Affiliation Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada

  ⨯
• Bradley P. Coe,

  Affiliation Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada

  ⨯
• Raj Chari,

  Affiliation Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada

  ⨯
• Larissa A. Pikor,

  Affiliation Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada

  ⨯
• Kelsie L. Thu,

  Affiliation Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada

  ⨯
• Luisa M. Solis,

  Affiliation Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Maria I. Nunez,

  Affiliation Departments of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Carmen Behrens,

  Affiliation Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• John Yee,

  Affiliation Department of Surgery, Vancouver General Hospital, Vancouver, British Columbia, Canada

  ⨯
• John English,

  Affiliation Department of Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada

  ⨯
• Nevin Murray,

  Affiliation Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada

  ⨯
• Ming-Sound Tsao,

  Affiliation Department of Pathology, University Health Network – Princess Margaret Hospital and Ontario Cancer Institute, University of Toronto, Toronto, Ontario, Canada

  ⨯
• John D. Minna,

  Affiliation Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America

  ⨯
• Adi F. Gazdar,

  Affiliation Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America

  ⨯
• Ignacio I. Wistuba,

  Affiliations Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America, Departments of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Calum E. MacAulay,

  Affiliation Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada

  ⨯
• Stephen Lam,

  Affiliation Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada

  ⨯
•  [ ... ],
• Wan L. Lam

  Affiliation Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada

  ⨯
• [ view all ]
• [ view less ]